PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsSucralfate
Sucralfate
Carafate, Sucralfate (sucralfate) is an unknown pharmaceutical. Sucralfate was first approved as Carafate on 1982-01-01. It is used to treat duodenal ulcer, esophagitis, gastritis, pneumonia, and stomach ulcer amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
stomatognathic diseasesD009057
respiratory tract diseasesD012140
Trade Name
FDA
EMA
Carafate, Sucralfate (discontinued: Sucralfate)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sucralfate
Tradename
Company
Number
Date
Products
CARAFATEAbbVieN-018333 RX1982-01-01
1 products, RLD, RS
CARAFATEAbbVieN-019183 RX1993-12-16
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
carafateNew Drug Application2024-05-21
sucralfateANDA2025-07-01
sulcralfateANDA2010-05-27
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A02: Drugs for acid related disorders
— A02B: Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
— A02BX: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) in atc
— A02BX02: Sucralfate
HCPCS
No data
Clinical
Clinical Trials
265 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MyalgiaD063806—M79.1———134
PneumoniaD011014EFO_0003106J18———123
UlcerD014456MPATH_579————112
DyspepsiaD004415EFO_0008533K30———112
HerniaD006547—K40-K46———112
Liver neoplasmsD008113EFO_1001513C22.0—1—1—2
Opioid-related disordersD009293EFO_0005611F11———1—1
Ventilator-associated pneumoniaD053717EFO_1001865J95.851———1—1
Disease susceptibilityD004198—————1—1
Coronary diseaseD003327—————1—1
Show 8 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative painD010149—G89.18——1—56
StomatitisD013280EFO_1001904K12.1—11—35
MucositisD052016EFO_1001898———2—35
Sleep wake disordersD012893—G47——1—23
EsophagitisD004941HP_0100633K20111——3
AnxietyD001007EFO_0005230F41.1——1—23
Head and neck neoplasmsD006258————2——2
Female genital neoplasmsD005833————1—12
ChondrocalcinosisD002805—M11.2——1——1
Human influenzaD007251EFO_0007328J11.1—11——1
Show 7 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Rotator cuff injuriesD000070636—M75.1—1——67
NeoplasmsD009369—C80—2——35
Breast neoplasmsD001943EFO_0003869C5012——35
Neck painD019547—M54.2—1——34
Rectal neoplasmsD012004———2——13
HypertensionD006973EFO_0000537I10—1——23
Respiratory aspirationD053120EFO_1001839——1——23
Covid-19D000086382—U07.1—1——23
Liver cirrhosisD008103EFO_0001422K74.0—1——12
FibrosisD005355———1——12
Show 23 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———4———48
Wounds and injuriesD014947—T14.81———45
HemorrhageD006470MP_0001914R581———23
Spinal cord injuriesD013119EFO_1001919—1———12
Type 2 diabetes mellitusD003924EFO_0001360E111————1
Diabetes mellitusD003920EFO_0000400E08-E131————1
Eosinophilic esophagitisD057765EFO_0004232K20.01————1
MalariaD008288EFO_0001068B541————1
Falciparum malariaD016778EFO_0007444B501————1
Thoracic injuriesD013898—S20-S291————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
StrokeD020521EFO_0000712I63.9————1212
SyndromeD013577——————1010
Muscle spasticityD009128——————88
Low back painD017116—M54.5————88
Back painD001416—M54————88
Cerebral palsyD002547—G80————77
PainD010146EFO_0003843R52————77
ParalysisD010243——————55
Shoulder painD020069—M25.51————55
FatigueD005221—R53.83————55
Show 214 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSucralfate
INNsucralfate
Description
Sucralfate, sold under various brand names, is a medication used to treat stomach ulcers, gastroesophageal reflux disease (GERD), radiation proctitis, and stomach inflammation and to prevent stress ulcers. Its usefulness in people infected by H. pylori is limited. It is used by mouth (for upper GIT ulcers) and rectally (for radiation proctitis).
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O=S(=O)(OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O)O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O
Identifiers
PDB—
CAS-ID54182-58-0
RxCUI—
ChEMBL IDCHEMBL3989780
ChEBI ID—
PubChem CID6398525
DrugBankDB00364
UNII IDXX73205DH5 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Carafate – Allergan
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Carafate – Warner Chilcott
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Sucralfate
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 15,875 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,365 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use